Jurgen Figys

Phone: +
7, Rue Joseph Stevens
Brussels B - 1000

Jurgen Figys joined Crowell & Moring's Brussels office as an associate in April 2013. His practice focuses primarily upon intellectual property and life sciences.

Jurgen is one of the few lawyers in Belgium also to be trained as a biomedical scientist. He is therefore able to combine his scientific reasoning with his legal knowledge, a considerable asset in the technology-driven IP field.

Jurgen predominantly works with clients in the pharmaceutical and biotechnology industry, with a particular focus on complex patent litigation and regulatory advice. He is ranked as a Next Generation Lawyer for Healthcare & Life Sciences in the 2017-2019 editions of Legal 500 EMEA. Jurgen was also personally mentioned in Legal 500 EMEA, 2017 for his patent infringement work relating to pharmaceuticals, medical devices and biotechnology, and he was described as “standing out” as a good litigator for Healthcare and Life Sciences.

He has particular experience in patent litigation with regard to invalidity, third-party opposition proceedings against counterfeit seizure, and preliminary injunction proceedings. His pre-contentious experience includes freedom-to-operate patent analysis and drafting protective letters. Jurgen is also involved in a number of trademark cases, such as parallel import litigation.

Within life sciences, he provides strategic regulatory advice to pharmaceutical and biotech companies as well as national and European industry associations. His experience covers a broad range of regulatory issues like data exclusivity, EU marketing authorizations, pricing and reimbursement of medicinal products, advertising, medical devices, clinical trials, and data. Digital transformation in the health sector is also one of his main focus areas. In cooperation with his U.S. colleagues, Jurgen also assists European to comply with FDA regulations.

Thanks to his scientific background, Jurgen is also able to advise clients on other EU regulatory issues with a technical angle. Over the last few years, Jurgen has developed an impressive, substantive knowledge of REACH through his work for a wide range of U.S. and EU-based clients. He also regularly advises on CLP issues. In addition to providing legal and strategic advice on REACH/CLP compliance, Jurgen is able in particular to assist clients with their more science-driven submissions to the European Chemicals Agency (ECHA) (preliminary risk assessments of potential chemicals of concern, etc.).

Prior to joining Crowell & Moring, Jurgen worked for ten years at the Free University of Brussels as a Ph.D. student and as a director of successive scientific studies for the Belgian Ministry of Defense, performing research on cell metabolism, apoptosis and cancer physiology. The design of a non-natural linear constrained peptide library was one of the main achievements of his project.

Jurgen is a frequent speaker at professional conferences, both on IP and regulatory topics, and teaches a course on patent enforcement to biomedical students at the University of Antwerp. He is also an active member of the International Association for the Protection of Intellectual Property (AIPPI).


Admitted to practice: in Belgium and before the European Court

Speeches & Presentations

  • "Digital Health Roundtable," Brussels, Belgium (April 24, 2019). Moderator: Maarten Stassen. Speakers: Jodi Daniel, Frederik Van Remoortel, Jurgen Figys, Evelina Roegiers, Evi Mattioli, and Judith Bussé.
  • "REACH," IJE/IBJ Deep Dive - Product Liability & Security in the EU and Belgium: Handling the Risks Associated with Defective or Non-Compliant Products, Brussels (December 6, 2018). Presenter: Jurgen Figys.
  • "Medical Devices," IJE/IBJ Deep Dive - Product Liability & Security in the EU and Belgium: Handling the Risks Associated with Defective or Non-Compliant Products, Brussels (December 6, 2018). Presenter: Jurgen Figys.
  • "The Importance of a Good IP Strategy – What Needs to be Done and Why," IBJ-IJE Seminar, Brussels, Belgium (October 5, 2017). Presenters: Kristof Roox, Jan-Diederik Lindemans, Jurgen Figys and Judith Bussé.
  • "Importing into the EU under REACH," International Compliance Professionals Association’s (ICPA) Annual European Conference, Dublin, Ireland (June 11-13, 2017). Speaker: Jurgen Figys.


  • "Avoiding Pesticide Data Compensation Disputes in the EU," Agrow (July 23, 2019). Authors: Peter Gray and Jurgen Figys.
  • "Counterfeit Seizures Proceedings in Belgium – An Update," Cahiers Antwerp Brussels Ghent (August 29, 2017). Authors: Christian Dekoninck, Jurgen Figys and Judith Bussé.
  • "Jouer avec les limites de l'usage off-label?" Le Journal du Médecin 2394, 39 (February 13, 2015). Author: Jurgen Figys
  • "De Minimis in Belgian Patent Law," I.R.D.I. (January 1, 2015). Authors: Kristof Roox and Jurgen Figys.
  • "De exclusieve bevoegdheid van de rechtbank van koophandel en het hof van beroep te Brussel in het nieuwe Wetboek intellectuele eigendom (Boek XI van het WER)" RABG (December 2014). Author: Jurgen Figys.
  • "Grenzen aan off-label gebruik?" [Limits to off-label use?], Artsenkrant 2392, 27 (January 30, 2014). Author: Jurgen Figys.

Client Alerts & Newsletters

Media Mentions

Firm News & Announcements

Apr.16.2019 Legal 500 EMEA Recommends Crowell & Moring in 11 Practice Areas and Recognizes 14 Lawyers
Jan.03.2019 Crowell & Moring Elects Eight New Partners and Promotes 21 Associates to Counsel
Apr.25.2018 Legal 500 Europe, Middle East & Africa Recommends Crowell & Moring in 11 Practice Areas and Recognizes Three Individuals
May.11.2017 Legal 500 Europe, Middle East & Africa Recommends Crowell & Moring in 12 Practice Areas and Names Three Lawyers to Leading Individuals List